Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- CheckyesterdayChange DetectedThe site revision label changes from v3.8.0 to v3.8.1, with no change to the study record content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check29 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.8%

- Check44 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check65 days agoChange DetectedThe record history now includes a new revision entry for v3.7.0 and removes the v3.6.6 entry, updating the version history shown on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.6.6 is added to the study's history and the previous revision v3.6.5 is removed. This reflects an update to the page's version history rather than substantive changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.